Mentzelopoulos, Spyros D. https://orcid.org/0000-0003-1159-8282
Koliantzaki, Iosifina
Karvouniaris, Marios
Vrettou, Charikleia
Mongardon, Nicolas
Karlis, George
Makris, Demosthenes
Zakynthinos, Epaminondas
Sourlas, Sotirios
Aloizos, Stavros
Xanthos, Theodoros
Zakynthinos, Spyros G.
Article History
First Online: 7 August 2018
Change Date: 19 September 2018
Change Type: Correction
Change Details: The original version of this article unfortunately contained a mistake. In Table 2, the frequency of Septic Shock reported just below the frequency of "At least 1 Episode of VAP" actually corresponds to the First (and not the Second) Episode of VAP during the postresuscitation period.
Compliance with Ethical Standard
:
: The authors declare that they have no conflict of interest.
: The individual patient data-based reanalysis protocol and subsequent amendments were approved by the institutional review boards (IRBs) of the three tertiary care centers that participated in the eligible randomized clinical trials (references 1 and 2). Due to the retrospective nature of the study and the use of an Excel datafile containing de-identified patient data during the conduct of the statistical analyses, the requirement for informed consent was waived. Before the initiation of the statistical analyses, access to electronic hospital records and electronic or hard-copy archives of the departments of Microbiology was authorized by the aforementioned IRBs, in order to (1) confirm prospectively collected data on infections/culture results (during the conduct of the included studies) and (2) retrospectively collect pertinent data on antibiotic resistance. Original protocol IRB approval numbers were as follows: Evaggelismos Hospital approval No. 14/9/1/2015; 401 Greek Army Hospital approval No. 3/2015/5/2/2015; Larissa University Hospital approval No. 58905/2014/14/1/2015. The protocol is registered with (Identifier: NCT02408939).